Works by Yu, Ai-Ming

Results: 35

Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models.

Published in:

Drug Metabolism Reviews, 2011, v. 43, n. 1, p. 27, doi. 10.3109/03602532.2010.512294

By:

Jiang, Xi-Ling;
Gonzalez, Frank J.;
Yu, Ai-Ming

Publication type:

Article

Polymorphic Cytochrome P450 2D6: Humanized Mouse Model and Endogenous Substrates.

Published in:

Drug Metabolism Reviews, 2004, v. 36, n. 2, p. 243, doi. 10.1081/DMR-120034000

By:

Yu, Ai‐Ming;
Idle, Jeffrey R.;
Gonzalez, Frank J.

Publication type:

Article

A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.

Published in:

PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0209941

By:

Alegre, Fernando;
Ormonde, Amanda R.;
Snider, Kellie M.;
Woolard, Kevin;
Yu, Ai-Ming;
Wittenburg, Luke A.

Publication type:

Article

N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis.

Published in:

Carcinogenesis, 2014, v. 35, n. 10, p. 2264, doi. 10.1093/carcin/bgu174

By:

Bi, Hui-Chang;
Pan, Yu-Zhuo;
Qiu, Jing-Xin;
Krausz, Kristopher W.;
Li, Fei;
Johnson, Caroline H.;
Jiang, Chang-Tao;
Gonzalez, Frank J.;
Yu, Ai-Ming

Publication type:

Article

Bioengineered miR‐34a targets MPV17L2 to control cancer cell mitochondrial functions.

Published in:

FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R4394

By:

Tu, Meijuan;
Yi, Wanrong;
Yu, Ai‐Xi;
Lin, Jun;
Yu, Ai‐Ming

Publication type:

Article

Fully‐humanized bioengineered miR‐1291 modulates key nutrient transport and metabolism to exert synergistic anticancer effects with chemotherapeutics.

Published in:

FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.02585

By:

Tu, Mei‐Juan;
Liu, Zhenzhen;
Deng, Linglong;
Zhang, Chao;
Yu, Ai‐Ming

Publication type:

Article

Bioengineered microRNAs in the control of folate cycle related one‐carbon metabolism in NSCLC metabolism.

Published in:

FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.03377

By:

Chen, Yixin;
Liu, Zhenzhen;
Tu, Meijuan;
Batra, Neelu;
Bi, Huichang;
Yu, Ai‐ming

Publication type:

Article

MiR‐124‐3p signaling in the control of metastasis‐related cytoskeleton organization, cell junctions and adhesion.

Published in:

FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.02586

By:

Deng, Linglong;
Petrek, Hannah;
Tu, Mei‐Juan;
Yu, Ai‐Ming

Publication type:

Article

Altered expression of small heterodimer partner governs CYP2D6 induction during pregnancy in CYP2D6‐humanized mice (1141.2).

Published in:

FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.1141.2

By:

Jeong, Hyunyoung;
Pan, Xian;
Koh, Kwihye;
Yu, Ai‐ming;
Isoherranen, Nina

Publication type:

Article

Induction of CYP2D6 Expression during Pregnancy Is Associated with an Increased Activity of Hepatocyte Nuclear Factor 4α.

Published in:

FASEB Journal, 2013, v. 27, p. 1102.3, doi. 10.1096/fasebj.27.1_supplement.1102.3

By:

PAN, XIAN;
Koh, Kwihye;
Yu, Ai‐Ming;
Jeong, Hyunyoung

Publication type:

Article

Effects of protein kinase C on M-phase promoting factor in early development of fertilized mouse eggs.

Published in:

Cell Biochemistry & Function, 2004, v. 22, n. 5, p. 291, doi. 10.1002/cbf.1103

By:

Yu, Bing-zhi;
Zheng, Jie;
Yu, Ai-ming;
Shi, Xiu-yan;
Liu, Ying;
Wu, Di-di;
Fu, Wei;
Yang, Jianing

Publication type:

Article

Bioengineered non-coding RNA agent (BERA) in action.

Published in:

Bioengineered, 2016, v. 7, n. 6, p. 411, doi. 10.1080/21655979.2016.1207011

By:

Duan, Zhijian;
Yu, Ai-Ming

Publication type:

Article

Bioengineering of noncoding RNAs for research agents and therapeutics.

Published in:

Wiley Interdisciplinary Reviews: RNA, 2016, v. 7, n. 2, p. 186, doi. 10.1002/wrna.1324

By:

Ho, Pui Yan;
Yu, Ai-Ming

Publication type:

Article

Inside Cover Image, Volume 7, Issue 2.

Published in:

Wiley Interdisciplinary Reviews: RNA, 2016, v. 7, n. 2, p. ii, doi. 10.1002/wrna.1346

By:

Ho, Pui Yan;
Yu, Ai-Ming

Publication type:

Article

Pharmacokinetic Analysis of Huangqi Guizhi Wuwu Decoction on Blood and Brain Tissue in Rats with Normal and Cerebral Ischemia-Reperfusion Injury by Microdialysis with HPLC-MS/MS.

Published in:

Drug Design, Development & Therapy, 2020, v. 14, p. 2877, doi. 10.2147/DDDT.S257020

By:

Zheng, Hao-Zhen;
Shen, Xiao;
He, Ying-Ying;
Yan, Xiang-Li;
Wang, Sheng-Xin;
Yu, Ai-Ming;
Wang, Li-Sheng

Publication type:

Article

A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.

Published in:

2022

By:

Chen, Justin A.;
Huynh, Jasmine C.;
Wu, Chun-Yi;
Yu, Ai-Ming;
Matsukuma, Karen;
Semrad, Thomas J.;
Gandara, David R.;
Li, Tianhong;
Riess, Jonathan W.;
Tam, Kit;
Mack, Philip C.;
Martinez, Anthony;
Mahaffey, Nichole;
Kelly, Karen L.;
Kim, Edward J.

Publication type:

journal article

Effects of Nicotinamide N-Methyltransferase on PANC-1 Cells Proliferation, Metastatic Potential and Survival Under Metabolic Stress.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2015, v. 35, n. 2, p. 710, doi. 10.1159/000369731

By:

Yu, Tao;
Wang, Yong-Tao;
Chen, Pan;
Li, Yu-Hua;
Chen, Yi-Xin;
Zeng, Hang;
Yu, ai-Ming;
Huang, Min;
Bi, Hui-Chang

Publication type:

Article

Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest.

Published in:

Scientific Reports, 2016, p. 26611, doi. 10.1038/srep26611

By:

Zhao, Yong;
Tu, Mei-Juan;
Wang, Wei-Peng;
Qiu, Jing-Xin;
Yu, Ai-Xi;
Yu, Ai-Ming

Publication type:

Article

The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug.

Published in:

Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00222

By:

Li, Dai-Feng;
Yuan, Ying;
Tu, Mei-Juan;
Hu, Xiang;
Li, Yi-Zhou;
Yi, Wan-Rong;
Li, Peng-Cheng;
Zhao, Yong;
Cheng, Zhen;
Yu, Ai-Ming;
Jian, Chao;
Yu, Ai-Xi

Publication type:

Article

The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies.

Published in:

Cancers, 2022, v. 14, n. 4, p. 949, doi. 10.3390/cancers14040949

By:

Berg, Anastasia L.;
Rowson-Hodel, Ashley;
Hu, Michelle;
Keeling, Michael;
Wu, Hao;
VanderVorst, Kacey;
Chen, Jenny J.;
Hatakeyama, Jason;
Jilek, Joseph;
Dreyer, Courtney A.;
Wheeler, Madelyn R.;
Yu, Ai-Ming;
Li, Yuanpei;
Carraway III, Kermit L.

Publication type:

Article

Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling.

Published in:

Cancers, 2021, v. 13, n. 7, p. 1672, doi. 10.3390/cancers13071672

By:

Zhang, Xiong;
Huang, Zenghong;
Wang, Junjian;
Ma, Zhao;
Yang, Joy;
Corey, Eva;
Evans, Christopher P.;
Yu, Ai-Ming;
Chen, Hong-Wu;
Robson, Craig N.

Publication type:

Article

MicroRNAs in non‐small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.

Published in:

Pharmacology Research & Perspectives, 2019, v. 7, n. 6, p. 1, doi. 10.1002/prp2.528

By:

Petrek, Hannah;
Yu, Ai‐Ming

Publication type:

Article

Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions.

Published in:

AAPS Journal, 2008, v. 10, n. 2, p. 242, doi. 10.1208/s12248-008-9028-5

By:

Yu, Ai-Ming

Publication type:

Article

Effects of Motherwort on Blood Hyperviscosity.

Published in:

American Journal of Chinese Medicine, 1989, v. 17, n. 1/2, p. 65, doi. 10.1142/S0192415X89000115

By:

Zou, Qi-zum;
Bi, Ru-gang;
Li, Jou-ming;
Feng, Jia-bing;
Yu, Ai-ming;
Chan, Hai-ping;
Zhen, Ming-xin

Publication type:

Article

Novel approaches for efficient in vivo fermentation production of noncoding RNAs.

Published in:

Applied Microbiology & Biotechnology, 2020, v. 104, n. 5, p. 1927, doi. 10.1007/s00253-020-10350-3

By:

Yu, Ai-Ming;
Batra, Neelu;
Tu, Mei-Juan;
Sweeney, Colleen

Publication type:

Article

Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs.

Published in:

Applied Microbiology & Biotechnology, 2019, v. 103, n. 15, p. 6107, doi. 10.1007/s00253-019-09934-5

By:

Petrek, Hannah;
Batra, Neelu;
Ho, Pui Yan;
Tu, Mei-Juan;
Yu, Ai-Ming

Publication type:

Article

The 2024 Nobel Prize in Physiology or Medicine: microRNA Takes Center Stage.

Published in:

Non-Coding RNA, 2024, v. 10, n. 6, p. 62, doi. 10.3390/ncrna10060062

By:

Calin, George A.;
Hubé, Florent;
Ladomery, Michael R.;
Delihas, Nicholas;
Ferracin, Manuela;
Poliseno, Laura;
Agnelli, Luca;
Alahari, Suresh K.;
Yu, Ai-Ming;
Zhong, Xiao-Bo

Publication type:

Article

Comparison of Three Computational Tools for the Prediction of RNA Tertiary Structures.

Published in:

Non-Coding RNA, 2024, v. 10, n. 6, p. 55, doi. 10.3390/ncrna10060055

By:

Mao, Frank Yiyang;
Tu, Mei-Juan;
Traber, Gavin McAllister;
Yu, Ai-Ming

Publication type:

Article

The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19).

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 17, p. 6412, doi. 10.3390/ijms21176412

By:

Batra, Neelu;
De Souza, Cristabelle;
Batra, Jyoti;
Raetz, Alan G.;
Yu, Ai-Ming

Publication type:

Article

Protein kinase a modulates Cdc25B activity during meiotic resumption of mouse oocytes.

Published in:

Developmental Dynamics, 2008, v. 237, n. 12, p. 3777, doi. 10.1002/dvdy.21799

By:

Zhang, Yang;
Zhang, Zhe;
Xu, Xiao-Yan;
Li, Xue-Song;
Yu, Meng;
Yu, Ai-Ming;
Zong, Zhi-Hong;
Yu, Bing-Zhi

Publication type:

Article

Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44572-6

By:

Luo, Zhangyi;
Huang, Yixian;
Batra, Neelu;
Chen, Yuang;
Huang, Haozhe;
Wang, Yifei;
Zhang, Ziqian;
Li, Shichen;
Chen, Chien-Yu;
Wang, Zehua;
Sun, Jingjing;
Wang, Qiming Jane;
Yang, Da;
Lu, Binfeng;
Conway, James F.;
Li, Lu-Yuan;
Yu, Ai-Ming;
Li, Song

Publication type:

Article

Wang Resin Bound Addition Reactions Under Microwave Irradiation.

Published in:

Synthetic Communications, 1999, v. 29, n. 9, p. 1595, doi. 10.1080/00397919908086140

By:

Yu, Ai-Ming;
Zhang, Zheng-Pu;
Yang, Hua-Zheng;
Zhang, Chun-Xiang;
Liu, Zhu

Publication type:

Article

DNA‐Thioguanine Nucleotides as a Marker for Thiopurine Induced Late Leukopenia after Dose Optimizing by NUDT15 C415T in Chinese Patients with IBD.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1236, doi. 10.1002/cpt.2730

By:

Zhu, Xia;
Chao, Kang;
Yang, Ting;
Wang, Xue‐ding;
Guan, Shaoxing;
Tang, Jian;
Xie, Wen;
Yu, Ai‐ming;
Yang, Qing fan;
Li, Miao;
Yang, Hong‐sheng;
Diao, Na;
Hu, Pin‐jin;
Gao, Xiang;
Huang, Min

Publication type:

Article

Comparing early liver graft function from heart beating and living-donors: A pilot study aiming to identify new biomarkers of liver injury.

Published in:

Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 5, p. 326, doi. 10.1002/bdd.2066

By:

Yang, Qi Joy;
Kluger, Michael;
Goryński, Krzysztof;
Pawliszyn, Janusz;
Bojko, Barbara;
Yu, Ai‐Ming;
Noh, Keumhan;
Selzner, Markus;
Jerath, Angela;
McCluskey, Stuart;
Pang, K. Sandy;
Wąsowicz, Marcin

Publication type:

Article

MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines.

Published in:

Biopharmaceutics & Drug Disposition, 2011, v. 32, n. 6, p. 355, doi. 10.1002/bdd.764

By:

Rodrigues, Alice C.;
Li, Xin;
Radecki, Laura;
Pan, Yu-Zhuo;
Winter, Jerrold C.;
Huang, Min;
Yu, Ai-Ming

Publication type:

Article